Related Experiment Video

Updated: Mar 3, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

43.0K

[Main immunoregulatory mechanisms that favor breast cancer development]

Gina Stella García-Romo1, Karen Guadalupe García-Castillo2, Álvaro Díaz-Rodríguez2

  • 1Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, Edo. de México, México.

Gaceta Medica De Mexico
|May 6, 2017
PubMed

Insights

Breast cancer remains a global health challenge. This review explores tumor microenvironment immunoregulatory mechanisms to improve immunotherapy efficacy.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Breast cancer is the most common cancer and leading cause of cancer death in women worldwide.
  • Despite advances in diagnosis and treatment, immunotherapy has shown limited efficacy.
  • This limitation may stem from suppressive mechanisms within the tumor microenvironment.

Purpose of the Study:

  • To review immunoregulatory mechanisms in breast cancer.
  • To understand the tumor microenvironment's role in immunotherapy failure.
  • To inform the development of novel immunotherapy strategies.

Main Methods:

  • Literature review of existing studies on breast cancer immunology.
  • Analysis of immunoregulatory mechanisms within the tumor microenvironment.
  • Discussion of clinical trial outcomes for immunotherapies.

Main Results:

  • The tumor microenvironment contains suppressive elements hindering effective anti-cancer immunity.
  • Specific immunoregulatory pathways in breast cancer influence treatment response.
  • Understanding these mechanisms is crucial for overcoming immunotherapy resistance.

Conclusions:

  • Targeting tumor microenvironment immunoregulatory mechanisms is essential for enhancing breast cancer immunotherapy.
  • Further research into these mechanisms will guide the design of more effective cancer treatments.
  • Developing new treatment strategies requires a deep understanding of tumor immunology.

More Related Videos

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
52.6K